We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+9.9%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$30.8B
AUM Growth
+$2.83B
(+10%)
Cap. Flow
+$314M
Cap. Flow
% of AUM
1.02%
Top 10 Holdings %
Top 10 Hldgs %
29.43%
Holding
995
New
101
Increased
392
Reduced
278
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$434M |
| 2 |
Estee Lauder
EL
|
+$90.8M |
| 3 |
Visa
V
|
+$90M |
| 4 |
Amphenol
APH
|
+$67.6M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$57.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Idexx Laboratories
IDXX
|
+$409M |
| 2 |
CTXS
Citrix Systems Inc
CTXS
|
+$322M |
| 3 |
Apple
AAPL
|
+$115M |
| 4 |
TotalEnergies
TTE
|
+$31.5M |
| 5 |
Deckers Outdoor
DECK
|
+$27.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.08% |
| 2 | Healthcare | 15.56% |
| 3 | Financials | 11.89% |
| 4 | Industrials | 9.57% |
| 5 | Energy | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Brunswick
BC
$5.19B
| $622K | ﹤0.01% |
13,500
| – | – |
|
|
MWE
602
DELISTED
MARKWEST ENERGY PARTNERS, LP
MWE
| $622K | ﹤0.01% |
9,400
| – | – |
|
|
MACK
603
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $619K | ﹤0.01% |
14,763
| – | – |
|
604
Prologis
PLD
$138B
| $616K | ﹤0.01% |
16,668
+8,206
| +97% | +$316K |
|
605
Vertex Pharmaceuticals
VRTX
$121B
| $610K | ﹤0.01% |
8,215
+4,765
| +138% | +$332K |
|
|
CRZO
606
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $610K | ﹤0.01% |
13,630
| – | – |
|
|
FISV
607
Fiserv Inc
FISV
$27.2B
| $607K | ﹤0.01% |
20,560
-260
| -1% | -$7.01K |
|
|
DRC
608
DELISTED
DRESSER-RAND GROUP INC
DRC
| $602K | ﹤0.01% |
10,100
+2,450
| +32% | +$145K |
|
609
Reinsurance Group of America
RGA
$15.7B
| $597K | ﹤0.01% |
7,711
-2,439
| -24% | -$178K |
|
|
BEAM
610
DELISTED
BEAM INC COM STK (DE)
BEAM
| $594K | ﹤0.01% |
8,716
+936
| +12% | +$63.2K |
|
|
NVO
611
Novo Nordisk
NVO
$216B
| $593K | ﹤0.01% |
+32,100
| New | +$559K |
|
612
Adobe
ADBE
$89.5B
| $592K | ﹤0.01% |
9,879
-540
| -5% | -$29.8K |
|
|
LM
613
DELISTED
Legg Mason, Inc.
LM
| $591K | ﹤0.01% |
+13,606
| New | +$528K |
|
|
CRAY
614
DELISTED
Cray, Inc.
CRAY
| $589K | ﹤0.01% |
21,450
+4,000
| +23% | +$94.1K |
|
615
Oneok
OKE
$58.7B
| $588K | ﹤0.01% |
10,811
-97
| -0.9% | -$4.86K |
|
|
CTRA
616
DELISTED
Coterra Energy
CTRA
| $587K | ﹤0.01% |
15,155
+1,850
| +14% | +$66K |
|
617
Liberty Media Series A
FWONA
$22.3B
| $587K | ﹤0.01% |
22,561
+5,573
| +33% | +$148K |
|
618
HP
HPQ
$23.5B
| $583K | ﹤0.01% |
+45,887
| New | +$527K |
|
|
GLPW
619
DELISTED
GLOBAL POWER EQUIPMENT GROUP INC COMMON NEW
GLPW
| $569K | ﹤0.01% |
29,111
-10,981
| -27% | -$215K |
|
|
PDCE
620
DELISTED
PDC Energy, Inc.
PDCE
| $567K | ﹤0.01% |
10,650
| – | – |
|
621
O'Reilly Automotive
ORLY
$72.4B
| $566K | ﹤0.01% |
65,985
+21,810
| +49% | +$184K |
|
622
United Natural Foods
UNFI
$3.01B
| $564K | ﹤0.01% |
7,481
+50
| +0.7% | +$3.53K |
|
623
Voya Financial
VOYA
$8.94B
| $562K | ﹤0.01% |
16,000
| – | – |
|
624
Invesco Next Gen Media and Gaming ETF
GGME
$44M
| $561K | ﹤0.01% |
21,070
+3,082
| +17% | +$75.6K |
|
625
iShares Select Dividend ETF
DVY
$24B
| $555K | ﹤0.01% |
7,785
-6,395
| -45% | -$445K |
|
Similar funds
QCM
Brown Advisory's Q4 2013 Portfolio in Review
As of Q4 2013, Brown Advisory held 995 positions worth $30.8B, up 10% from $28B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Brown Advisory's Q4 2013 filing shows 101 new, 392 increased, 278 reduced and 51 closed positions. Its largest new stake was Plains GP Holdings: 157,910 shares worth $11.3M. The largest sale was Idexx Laboratories, an estimated $409M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- Brown Advisory's largest Q4 2013 buy was Plains GP Holdings: 157,910 shares worth $11.3M.
- Brown Advisory added most to Gilead Sciences in Q4 2013, an estimated $434M increase.
- Brown Advisory's biggest Q4 2013 reduction was Idexx Laboratories, cutting an estimated $409M.
- Brown Advisory fully exited Ariad Pharmaceuticals Inc in Q4 2013, selling an estimated $19.5M.
- Brown Advisory's ten largest holdings make up 29% of its $30.8B portfolio in Q4 2013.
- Brown Advisory opened 101 new positions and closed 51 in Q4 2013.
- Brown Advisory's portfolio value rose 10% quarter-over-quarter to $30.8B.
Based on Brown Advisory's 13F filing for Q4 2013, filed 11 Feb 2014.